semaglutide for liver Heals Fat and Fibrosis Directly | Robert Gabbay MD, PhD posted on the topic Novo Nordisk's Wegovy Gets US
Description
Overall, across PBMs the consensus access policy is very tight : PBMs uniformly require prior authorization for GLP-1s used for obesity, almost always mandate step therapy, and site-of-care is typically limited (e.g
Red flag: Severe persistent nausea or vomiting after every meal
May 2025: Bayer is reportedly making a renewed effort to resolve some Roundup lawsuits through another settlement
Diabetic GLP1s are covered on tier 2 with a PA
it simply escalates on schedule
This could contribute to more pronounced or unexpected side effects compared to regulated brands like Ozempic or Wegovy
